Clinical Trial

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

Study acronym: FIT T2D
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate the feasibility and acceptability of a 12-week intervention utilizing a Fitbit and artificial intelligence (AI)-delivered diabetes self-management education and support (DSMES) with tailored text messages. The main question it aims to answer is: Does providing a wearable fitness and activity tracker plus AI-tailored and DSMES improve clinical outcomes for patients with type 2 diabetes? Participants will complete a baseline visit, wear a Fitbit and answer text messages for 12-weeks, and complete by a final visit.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-06-02; most recent amendment 2026-05-15.
Status change: Not Yet Recruiting → Recruiting 2025-09-12
Trial Details
NCT Number NCT07005362
Lead Sponsor University of Colorado, Denver
Collaborators: American Academy of Family Physicians
Conditions Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), T2DM (Type 2 Diabetes Mellitus), T2D, T2DM, Remote Patient Monitoring, Artificial Intelegence
Enrollment 36 participants
Start Date 2025-09-03
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-19